tiprankstipranks
Kissei Pharmaceutical Co (JP:4547)
:4547
Japanese Market

Kissei Pharmaceutical Co (4547) Financial Statements

Compare
0 Followers

Kissei Pharmaceutical Co Financial Overview

Kissei Pharmaceutical Co's market cap is currently ¥152.82B. The company's EPS TTM is ¥265.192; its P/E ratio is 13.82; and it has a dividend yield of 2.42%. Kissei Pharmaceutical Co is scheduled to report earnings on February 3, 2025, and the estimated EPS forecast is ¥83.08. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue¥ 75.58B¥ 67.49B¥ 65.38B¥ 69.04B¥ 63.24B
Gross Profit¥ 37.34B¥ 32.38B¥ 31.24B¥ 32.72B¥ 34.91B
Operating Income¥ 4.02B¥ -1.13B¥ -1.40B¥ 1.50B¥ 1.86B
EBITDA¥ 18.72B¥ 17.81B¥ 20.26B¥ 10.65B¥ 7.21B
Net Income¥ 11.16B¥ 10.53B¥ 12.92B¥ 5.29B¥ 2.82B
Balance Sheet
Cash & Short-Term Investments¥ 45.93B¥ 49.60B¥ 53.15B¥ 44.45B¥ 59.67B
Total Assets¥ 260.93B¥ 221.20B¥ 238.09B¥ 268.86B¥ 231.79B
Total Debt¥ 1.34B¥ 1.49B¥ 1.64B¥ 1.74B¥ 1.76B
Net Debt¥ -21.55B¥ -24.40B¥ -28.37B¥ -18.71B¥ -34.57B
Total Liabilities¥ 39.79B¥ 26.39B¥ 35.91B¥ 48.91B¥ 38.83B
Stockholders' Equity¥ 220.03B¥ 193.90B¥ 201.38B¥ 219.31B¥ 192.46B
Cash Flow
Free Cash Flow¥ -3.51B¥ -9.23B¥ -386.00M¥ -4.03B¥ 12.63B
Operating Cash Flow¥ -1.68B¥ -6.68B¥ 1.53B¥ -2.54B¥ 13.93B
Investing Cash Flow¥ 8.69B¥ 6.00B¥ 10.78B¥ -9.33B¥ 490.00M
Financing Cash Flow¥ -10.01B¥ -3.42B¥ -2.76B¥ -4.00B¥ -4.42B
Currency in JPY

Kissei Pharmaceutical Co Earnings and Revenue History

Kissei Pharmaceutical Co Debt to Assets

Kissei Pharmaceutical Co Cash Flow

Kissei Pharmaceutical Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis